Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
32,315,113
-
Total 13F shares
-
2,545,942
-
Share change
-
+1,427,543
-
Total reported value
-
$28,053,606
-
Put/Call ratio
-
267%
-
Price per share
-
$11.02
-
Number of holders
-
37
-
Value change
-
+$16,068,965
-
Number of buys
-
26
-
Number of sells
-
11
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2019
As of 31 Mar 2019,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,545,942 shares.
The largest 10 holders included
VANGUARD GROUP INC, Balyasny Asset Management LLC, Sofinnova Investments, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., EAM Investors, LLC, GOLDMAN SACHS GROUP INC, BARCLAYS PLC, and Tibra Equities Europe Ltd.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.